PHI with Parkinson's Disease

How does this condition affect your private health insurance?

Zitterlähmung, more commonly known as Parkinson's Disease, is a progressive neurodegenerative disorder primarily affecting the brain's dopamine-producing neurons. It leads to motor symptoms like tremors, bradykinesia (slow movement), rigidity, and postural instability. Non-motor symptoms such as cognitive impairment, sleep disorders, depression, and loss of smell are also common. The disease's exact cause is unknown but involves a combination of genetic and environmental factors. It typically progresses slowly over many years, significantly impacting quality of life as symptoms worsen. While there is no cure, treatments aim to manage symptoms and improve daily functioning.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Symptoms develop gradually, often over months to a few years, before diagnosis.

Duration of Illness (Lifetime)

Chronic, progressive disease lasting for decades until end of life.

Cost of Treatment (Initial)

Moderate to high (initial diagnosis, neurologist consultations, imaging, and medication initiation often cost several thousands to tens of thousands of USD).

Cost of Treatment (Lifetime)

Very high (tens of thousands to hundreds of thousands of USD, potentially over a million USD, due to lifelong medication, therapies, potential surgeries like DBS, and long-term care needs).

Mortality Rate

Not directly fatal, but complications such as falls, aspiration pneumonia, and infections significantly increase mortality risk compared to the general population.

Risk of Secondary Damages

Very high (e.g., falls leading to fractures, depression, anxiety, dementia, swallowing difficulties, speech problems, constipation, sleep disorders, motor fluctuations, dyskinesia from medication).

Probability of Full Recovery

Extremely low, as it is a progressive neurodegenerative disease with no known cure or possibility of complete recovery.

Underlying Disease Risk

Not typically associated with 'underlying diseases' causing it, but common comorbidities include depression (up to 50%), anxiety, sleep disorders (e.g., REM sleep behavior disorder), and hypertension. Genetic predispositions may exist.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.